Publication | Closed Access

Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate

Tumor BiologyHuman Tumor CellsMedicineImmunologyPharmacologyImmune Checkpoint InhibitorTumor TargetingMonoclonal Antibody-enzyme ConjugateAnti-cancer AgentCancer TreatmentImmunotherapyOncologyCancer Research